Evaluation of pretreatment telomere length as a prognostic marker in intermediate-risk acute myeloid leukemia.
Runxia GuJingjing CaoShuning WeiXiaoyuan GongYing WangYingchang MiJunping ZhangShaowei QiuQing RaoMin WangHui WeiJian-Xiang WangPublished in: International journal of laboratory hematology (2021)
Short TL is an independent prognostic factor for poor prognosis in patients with IRC-AML and may represent a novel mechanism that links genomic stability and disease progression.